Cerity Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Sell
1,170
-274
-19% -$131K ﹤0.01% 2159
2025
Q4
$841K Buy
1,444
+481
+50% +$246K ﹤0.01% 1805
2025
Q3
$442K Sell
963
-170
-15% -$63.4K ﹤0.01% 2056
2025
Q2
$343K Sell
1,133
-278
-20% -$82.8K ﹤0.01% 2075
2025
Q1
$467K Sell
1,411
-56
-4% -$18.4K ﹤0.01% 1794
2024
Q4
$408K Buy
+1,467
New +$413K ﹤0.01% 1885
2024
Q3
Sell
-1,135
Closed -$318K 2579
2024
Q2
$318K Sell
1,135
-7
-0.6% -$1.67K ﹤0.01% 1787
2024
Q1
$305K Buy
+1,142
New +$269K ﹤0.01% 1858
2023
Q2
Sell
-914
Closed -$221K 1835
2023
Q1
$221K Buy
914
+89
+11% +$24.3K ﹤0.01% 1665
2022
Q4
$239K Buy
+825
New +$80.7K ﹤0.01% 1242

Other funds holding MDGL